Legalization
×
Site Menu
Everything
International Coverage
Legalization
Local Collectives
Investing
Mental Health
Recreation
Mushroom Culture
New Tech
Publications
Mushroom Science
Physical Benefits
FDA nod fuels Filament’s psychedelics push, but cash running short
3 days ago
4
$6M bankrolls Enveric pipeline partnering, depression program
3 days ago
5
Well-funded Alto Neuroscience’s losses widen in the first quarter
3 days ago
6
Atai Life Sciences CEO to step down amid solid first quarter
3 days ago
5
Enveric signs deal with MindBio
4 days ago
8
AbbVie, Gilgamesh Pharmaceuticals enter psychiatric drug deal
5 days ago
7
Relmada loses another $21.8M, makes progress with clinical trials
5 days ago
7
DEA psychedelics ban hearing halted by lawsuit
1 week ago
19
Horizons talk shifts from investors to insurance
1 week ago
20
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
1 week ago
11
MindMed says it has enough cash to take it 2026
1 week ago
19
Compass Pathways keeps plugging away with its psilocybin study trials
1 week ago
13
Reunion Neuroscience raises $103 million
1 week ago
18
GH Research advances depression therapies, burns cash
2 weeks ago
18
Psyched Wellness reports slightly increased revenue
2 weeks ago
23
Compass Pathways, Journey Clinical to develop psilocybin treatment del...
2 weeks ago
18
MindBio to test LSD to treat menstrual mood symptoms
2 weeks ago
19
Mydecine will restate 2022 financials, lowering cash levels even furth...
3 weeks ago
23
Tryp Therapeutics, Exopharm merger approved by shareholders
3 weeks ago
16
Hypha Labs pivots to psilocybin with new mushroom tech
3 weeks ago
40
DEA resists permitting psilocybin for terminal patients under ‘Right t...
3 weeks ago
10
MDMA producer PharmAla issues 4.1M new shares to raise $750,000
3 weeks ago
17
Maine lawmakers pass bill to study psychedelic regulation
4 weeks ago
25
Clearmind signs agreement with Hebrew University for psychedelic compo...
4 weeks ago
24
Numinus reports declining revenue as the company restructures
1 month ago
26
Filament’s pivots pay off, nets $2.1M revenue in 2023
1 month ago
34
MindMed taps out of Cboe
1 month ago
23
Algernon sells Ifenprodil, zooms in on DMT for stroke care
1 month ago
43
Compass Pathways co-founders exit to pursue ‘broader goals’
1 month ago
50
Atai cash purse down nearly half despite lower spending
1 month ago
39
Atai nasal spray hits mark in depression study
1 month ago
37
Alto Neuroscience is enjoying a solid cash cushion
1 month ago
34
Enveric Biosciences pins hopes on licensing deals
1 month ago
37
Psychedelic therapy program to launch in Utah
1 month ago
37
Relmada Therapeutics trims losses, slashes research costs
1 month ago
25
Seelos Therapeutics swings and misses on ALS drug study
1 month ago
25
Swedish study looks at psychedelic treatments for teens with psychotic...
2 months ago
31
Cybin to raise $150 million through private placement
2 months ago
51
BlueSky Wellness scraps merger with Lucy Scientific
2 months ago
51
JAMA article urges more surveillance over ketamine treatments
2 months ago
49
Mynd Life Sciences cuts losses, but faces going concern doubts
2 months ago
70
Atai kicks off DMT Phase 1 study
2 months ago
45
Compass widens Q4 loss as patient hurdles slow trials
2 months ago
81
Braxia Scientific cash dwindles even as revenues rise
2 months ago
74
GH Research pushes forward with DMT trials, drug approvals
2 months ago
67
Red Light Holland loses C$1.2 million in latest quarter
2 months ago
47
Psyence reports no revenue in Q4, but returns a profit
2 months ago
72
Psilocybin treatment beats placebo in Incannex anxiety study
2 months ago
56
Clearmind trials new alcohol disorder fix
2 months ago
86
Enveric sells cannabis patents to focus on psilocin candidates
2 months ago
67
Prev.
1
2
3
4
Next
Last
Trending
1.
Steve Buscemi
2.
Fever vs Liberty
3.
Bundesliga
4.
Preakness 2024
5.
Rudy Giuliani
6.
Colorado Avalanche
7.
Dallas Stars
8.
Fury vs Usyk
9.
Bridgerton Season 3 Part 2
10.
Kensington Metropark alligator sighting
Popular
Therapists Are Unprepared to Talk to People About Taking Psychedelics
What We Know (and Don’t) About Magic Mushroom Paralysis
How To Talk With Your Kids About Psychedelics
Uniform Model Law on Plants and Fungi Medicines: A Better Path to Reregulation
Psychedellux: The Psychedelic Industry News For The Week